封面
市场调查报告书
商品编码
1300969

表观遗传学诊断市场规模、份额和趋势分析报告:按产品(试剂、试剂盒、仪器、□、服务)、按应用(肿瘤学、非肿瘤学)、按技术、按地区、细分市场趋势,2023 ~2030

Epigenetics Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Kits, Instruments, Enzymes, Services), By Application (Oncology, Non-oncology), By Technology, By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

表观遗传学诊断市场增长和趋势

根据 Grand View Research, Inc. 的最新研究报告,全球表观遗传学诊断市场规模在预测期内将以 15.10% 的复合年增长率扩大,预计到 2030 年预计到2020年将达到391.5亿美元。

这一增长是由重度抑郁症 (MDD) 患病率上升推动的。 据世界卫生组织称,到 2023 年,约 5% 的成年人将患有抑郁症。 此外,根据 NCBI 2022 年发布的一项研究,全球约有 2.8 亿人患有 MDD。 此外,表观遗传药物发现领域的技术进步也促进了增长。 根据 BioMed Central Ltd. 发表的研究,人们越来越关注构建选择性异构体抑製剂以提供抗肿瘤功效。

此外,公共和私人实体在表观遗传学领域的投资增加预计将在 2023-2030 年推动市场发展。 例如,2023 年 3 月,单剂量表观遗传编辑系统领域的领导者 Chroma Medicine, Inc. 完成了 1.35 亿美元的 B 轮融资。 该资金由谷歌风投牵头,用于表观遗传编辑技术领域的进步。

行业领导者正在采取各种策略来巩固其市场地位并扩大其客户群。 例如,2022 年 5 月,Cardio Diagnostics, Inc. 和 Mana Capital Acquisition Corp. 建立了业务联盟。 该交易的目的是创建一家上市公司,通过表观遗传学的应用来改变心血管疾病。 此外,2022 年 2 月,Element Biosciences 和 Dovetail Genomics 宣布建立合作伙伴关係,以展示 Dovetail 在 Element 的 AVITI 系统上的下一代测序文库製备服务的性能和价值。

COVID-19 大流行为表观遗传学研究人员创造了一个机会来研究 COVID-19 病毒对 DNA 甲基化变化和骨髓分化的影响,从而对市场产生积极影响。 根据NCBI 2022年发表的一项研究,表观遗传修饰不仅在维持细胞稳态和基因组方面发挥着重要作用,而且还提供了病毒感染的病因和发病机制的信息。

表观遗传学诊断市场报告亮点

  • 从产品来看,试剂领域在 2022 年占据市场主导地位,份额为 31.50%。 这种增长归因于表观遗传学研究中对试剂的需求不断增长。
  • 从技术角度来看,随着慢性病治疗需求的不断增长,DNA甲基化领域将在2022年占据最大的收入份额,达到46.73%。
  • 按应用划分,肿瘤学应用领域在 2022 年占据最大收入份额,达到 69.23%。 该细分市场的增长归因于癌症发病率的增加,对癌症领域表观遗传学研究的需求不断增加。
  • 由于拥有知名的市场参与者和技术先进的医疗保健基础设施,北美在 2022 年以 38.18% 的收入份额占据市场主导地位。 此外,意识的提高加上高研发支出预计将推动预测期内的增长。
  • 主要市场参与者包括 Roche Diagnostics、Thermo Fisher Scientific, Inc. Ltd.、Novartis AG、Element Biosciences, Inc.、Dovetail Genomics LLC.、Illumina, Inc.、ValiRx Plc.、Abcam plc. is。

内容

第一章调查方法及范围

  • 信息获取
  • 信息或数据分析
  • 市场范围和细分定义
  • 市场模式
    • 按公司市场份额进行市场调查
    • 区域分析

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第 3 章表观遗传学诊断市场变量、趋势和范围

  • 市场体系展望
    • 母公司市场前景
    • 相关/补充市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场製约因素分析
    • 市场机会分析
  • 表观遗传学诊断市场分析工具
    • 波特五力分析
    • PESTEL 分析
    • COVID-19 的影响分析

第四章产品业务分析

  • 表观遗传学诊断市场:产品变异分析
  • 试剂
    • 2018-2030 年试剂市场(百万美元)
  • 套件
    • 2018-2030 年套件市场(百万美元)
    • 芯片测序套件
    • 全基因组扩增试剂盒
    • 亚硫酸氢盐转换套件
    • RNA测序试剂盒
    • 其他
  • 设备
    • 2018-2030 年设备市场(百万美元)
    • □市场,2018-2030 年(百万美元)
  • 服务
    • 2018-2030 年服务市场(百万美元)

第五章应用业务分析

  • 表观遗传学诊断市场:应用的变异分析
  • 肿瘤学
    • 肿瘤市场,2018-2030 年(百万美元)
    • 实体瘤
    • 其他
  • 非肿瘤学
    • 非肿瘤市场,2018-2030 年(百万美元)
    • 炎症性疾病
    • 代谢性疾病
    • 感染
    • 心血管疾病
    • 其他

第 6 章技术业务分析

  • 表观遗传学诊断市场:技术波动分析
  • DNA甲基化
    • DNA 甲基化市场,2018-2030 年(百万美元)
  • 组蛋白甲基化
    • 2018-2030 年组蛋白甲基化市场(百万美元)
  • 组蛋白乙□化
    • 2018-2030 年组蛋白乙□化市场(百万美元)
  • 大非编码RNA
    • 大型非编码 RNA 市场,2018-2030 年(百万美元)
  • 微小RNA修饰
    • 2018-2030 年 MicroRNA 修饰市场(百万美元)
    • 2018-2030 年染色质结构市场(百万美元)

第七章区域业务分析

  • 2022 年和 2030 年表观遗传学诊断市场份额(按地区)
  • 北美
    • SWOT分析
    • 北美表观遗传学诊断市场,2018-2030 年(百万美元)
    • 美国
    • 加拿大
  • 欧洲
    • SWOT分析
    • 2018-2030 年欧洲表观遗传学诊断市场(百万美元)
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • SWOT分析
    • 亚太表观遗传学诊断市场,2018-2030 年(百万美元)
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 泰国
    • 韩国
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲表观遗传学诊断市场,2018-2030 年(百万美元)
    • 巴西
    • 墨西哥
    • 阿根廷
  • MEA
    • SWOT分析
    • MEA 表观遗传学诊断市场,2018-2030 年(百万美元)
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第 8 章竞争格局

  • 公司分类
  • 战略规划
  • 2022 年公司市场份额分析
  • 公司简介/列表
    • Roche Diagnostics
    • Thermo Fisher Scientific, Inc.
    • Eisai Co. Ltd.
    • Novartis AG
    • Element Biosciences, Inc.
    • Dovetail Genomics LLC.
    • Illumina, Inc.
    • ValiRx Plc.
    • Abcam plc.
Product Code: GVR-2-68038-831-2

Epigenetics Diagnostics Market Growth & Trends

The global epigenetics diagnostic market size is expected to reach USD 39.15 billion by 2030, expanding at a CAGR of 15.10% over the forecast period, according to a new study by Grand View Research, Inc. The growth is attributed to the rising incidence of major depressive disorder (MDD). According to WHO, in 2023, around 5% of adults suffer from depressive disorder. Furthermore, according to a study published by NCBI in 2022, around 280 million people are affected by MDD across the globe. Additionally, technological advancement in the field of epigenetic drug discovery is also contributing to the growth. A study published by BioMed Central Ltd. states that there is an increasing inclination towards selective isoform inhibitor construction to produce anti-tumor effects.

Moreover, increasing investment from public and private organizations in the field of epigenetics is anticipated to drive the market during 2023-2030. For instance, in March 2023, Chroma Medicine, Inc., a leader in single-dose epigenetic editing systems, completed a USD 135 million Series B funding. The financing was led by Google Ventures for the advancement in the field of epigenetic editing technology.

Key players in the industry are adopting various strategies to strengthen their market position and expand their customer base. For instance, in May 2022, Cardio Diagnostics, Inc., and Mana Capital Acquisition Corp. entered a business agreement. The goal of this agreement was to create a publicly listed company to transform cardiovascular disease through the application of epigenetics. Moreover, in February 2022, Element Bioscience, Inc., and Dovetail Genomics announced a partnership to demonstrate the performance and value of Dovetail's next-generation sequencing library prep service on Element's AVITI system.

The COVID-19 pandemic has positively impacted the market by creating opportunities for epigenetics researchers to study the impact of the COVID-19 virus on DNA methylation changes and myeloid differentiation. A study published by NCBI in 2022 states that epigenetic modification not only plays a crucial role in the maintenance of cellular homeostasis and the genome but also provides information about the cause and development of virus infection.

Epigenetics Diagnostics Market Report Highlights

  • Based on product, the reagent segment dominated the market with a share of 31.50% in 2022. The growth is attributed to the rising demand for reagents in epigenetic research studies.
  • Based on technology, the DNA methylation segment accounted for the largest revenue share of 46.73% in 2022, owing to its increasing demand in chronic disease treatment.
  • Based on application, the oncology application segment accounted for the largest revenue share of 69.23% in 2022. The segment growth is attributed to the increasing demand for epigenetics research in the field of cancer owing to its growing incidences.
  • North America dominated the market with a revenue share of 38.18% in 2022, owing to the presence of prominent market players and technologically advanced healthcare infrastructure. Moreover, rising awareness coupled with high R&D expenditure is anticipated to drive growth over the forecast period.
  • Some of the major players in the market are Roche Diagnostics, Thermo Fisher Scientific, Inc., Eisai Co. Ltd., Novartis AG, Element Biosciences, Inc., Dovetail Genomics LLC., Illumina, Inc., ValiRx Plc., and Abcam plc.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Information Procurement
  • 1.2. Information Or Data Analysis
  • 1.3. Market Scope & Segment Definition
  • 1.4. Market Model
    • 1.4.1. Market Study, By Company Market Share
    • 1.4.2. Regional Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Epigenetics Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cancer
      • 3.2.1.2. Rise in number of geriatric patients
      • 3.2.1.3. Expanding governmental initiatives in the epigenetics field
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Worries about diagnoses using epigenetics in terms of standardization
      • 3.2.2.2. Lack of skilled professionals
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Improvement in healthcare infrastructure in developing economies
  • 3.3. Epigenetics Diagnostics Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Epigenetics Diagnostics Market: Product Movement Analysis
  • 4.2. Reagents
    • 4.2.1. Reagents Market, 2018 - 2030 (USD Million)
  • 4.3. Kits
    • 4.3.1. Kits Market, 2018 - 2030 (USD Million)
    • 4.3.2. Chip Sequencing Kit
      • 4.3.2.1. Chip sequencing kit Market, 2018 - 2030 (USD Million)
    • 4.3.3. Whole Genomic Amplification kit
      • 4.3.3.1. Whole Genomic Amplification Kit Market, 2018 - 2030 (USD Million)
    • 4.3.4. Bisulfite Conversion Kit
      • 4.3.4.1. Bisulfite Conversion Kit Market, 2018 - 2030 (USD Million)
    • 4.3.5. RNA Sequencing Kit
      • 4.3.5.1. RNA Sequencing Kit Market, 2018 - 2030 (USD Million)
    • 4.3.6. Others
      • 4.3.6.1. Others Market, 2018 - 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market, 2018 - 2030 (USD Million)
  • 4.5. Enzymes
    • 4.5.1. Enzymes Market, 2018 - 2030 (USD Million)
  • 4.6. Services
    • 4.6.1. Services Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Epigenetics Diagnostics Market: Application Movement Analysis
  • 5.2. Oncology
    • 5.2.1. Oncology Market, 2018 - 2030 (USD Million)
    • 5.2.2. Solid Tumors
      • 5.2.2.1. Solid Tumors Market, 2018 - 2030 (USD Million)
    • 5.2.3. Others
      • 5.2.3.1. Others Market, 2018 - 2030 (USD Million)
  • 5.3. Non-oncology
    • 5.3.1. Non-oncology Market, 2018 - 2030 (USD Million)
    • 5.3.2. Inflammatory Diseases
      • 5.3.2.1. Inflammatory Diseases Market, 2018 - 2030 (USD Million)
    • 5.3.3. Metabolic Diseases
      • 5.3.3.1. Metabolic Diseases Market, 2018 - 2030 (USD Million)
    • 5.3.4. Infectious Diseases
      • 5.3.4.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
    • 5.3.5. Cardiovascular Diseases
      • 5.3.5.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
    • 5.3.6. Others
      • 5.3.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Technology Business Analysis

  • 6.1. Epigenetics Diagnostics Market: Technology Movement Analysis
  • 6.2. DNA Methylation
    • 6.2.1. DNA Methylation Market, 2018 - 2030 (USD Million)
  • 6.3. Histone Methylation
    • 6.3.1. Histone Methylation Market, 2018 - 2030 (USD Million)
  • 6.4. Histone Acetylation
    • 6.4.1. Histone Acetylation Market, 2018 - 2030 (USD Million)
  • 6.5. Large noncoding RNA
    • 6.5.1. Large noncoding RNA Market, 2018 - 2030 (USD Million)
  • 6.6. MicroRNA modification
    • 6.6.1. MicroRNA modification Market, 2018 - 2030 (USD Million)
    • 6.7.1. Chromatin Structure Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Epigenetics Diagnostics Market Share By Region, 2022 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. U.S. Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Reimbursement Scenario
      • 7.2.4.6. Canada Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.3. UK
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. UK Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. Germany Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. France Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Italy Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Spain Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Denmark Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Sweden Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Target Disease Prevalence
      • 7.3.10.3. Competitive Scenario
      • 7.3.10.4. Regulatory Framework
      • 7.3.10.5. Reimbursement Scenario
      • 7.3.10.6. Norway Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. Japan Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. China Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. India Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. Australia Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Thailand Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.4.8. South Korea
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. Reimbursement Scenario
      • 7.4.8.6. South Korea Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Brazil Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Reimbursement Scenario
      • 7.5.4.6. Mexico Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Reimbursement Scenario
      • 7.5.5.6. Argentina Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. South Africa Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. Saudi Arabia Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. UAE Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Regulatory Framework
      • 7.6.6.5. Reimbursement Scenario
      • 7.6.6.6. Kuwait Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Share Analysis, 2022
  • 8.4. Company Profiles/Listing
    • 8.4.1. Roche Diagnostics
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Type benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Thermo Fisher Scientific, Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Type benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Eisai Co. Ltd.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Type benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Novartis AG
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. Element Biosciences, Inc.
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Dovetail Genomics LLC.
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Illumina, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. ValiRx Plc.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Type benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Abcam plc.
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Type benchmarking
      • 8.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America Epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 6 U.S. Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 9 Canada Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 12 Europe Epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 15 Europe Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 16 UK Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 17 UK Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 18 UK Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 19 Germany Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 20 Germany Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 France Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 23 France Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 24 France Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 25 Italy Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 28 Spain Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 Denmark Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 32 Denmark Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 33 Denmark Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 34 Sweden Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 35 Sweden Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 36 Sweden Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 37 Norway Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 38 Norway Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 39 Norway Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 44 China Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 45 China Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 46 China Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Japan Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 49 Japan Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 50 India Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 51 India Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52 India Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 53 Australia Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 54 Australia Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 56 South Korea Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 59 Thailand Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 60 Thailand Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 61 Thailand Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 62 Latin America Epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 63 Latin America Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 64 Latin America Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65 Latin America Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 66 Brazil Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 67 Brazil Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 69 Mexico Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 70 Mexico Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 72 Argentina Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa Epigenetics diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 79 South Africa Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 85 UAE Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Epigenetics diagnostics market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Epigenetics diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait Epigenetics diagnostics market, by technology, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Epigenetics Diagnostics Market Segmentation
  • Fig. 8 Market Snapshot, 2022
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 PESTEL Analysis
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Global Epigenetics Diagnostics Market: Product Key Takeaways
  • Fig. 15 Global Epigenetics Diagnostics Market: Product Movement Analysis
  • Fig. 16 Global Epigenetics Diagnostics Market, For Reagents, 2018 - 2030 (USD Million)
  • Fig. 17 Global Epigenetics Diagnostics Market, For Kits, 2018 - 2030 (USD Million)
  • Fig. 18 Global Epigenetics Diagnostics Market, For Instruments, 2018 - 2030 (USD Million)
  • Fig. 19 Global Epigenetics Diagnostics Market, For Enzymes, 2018 - 2030 (USD Million)
  • Fig. 20 Global Epigenetics Diagnostics Market, For Services, 2018 - 2030 (USD Million)
  • Fig. 21 Global Epigenetics Diagnostics Market: Application Key Takeaways
  • Fig. 22 Global Epigenetics Diagnostics Market: Application Movement Analysis
  • Fig. 23 Global Epigenetics Diagnostics Market, For Oncology, 2018 - 2030 (USD Million)
  • Fig. 24 Global Epigenetics Diagnostics Market, For Non-oncology, 2018 - 2030 (USD Million)
  • Fig. 25 Global Epigenetics Diagnostics Market: Technology Key Takeaways
  • Fig. 26 Global Epigenetics Diagnostics Market: Technology Movement Analysis
  • Fig. 27 Global Epigenetics Diagnostics Market, For DNA Methylation, 2018 - 2030 (USD Million)
  • Fig. 28 Global Epigenetics Diagnostics Market, For Histone Methylation, 2018 - 2030 (USD Million)
  • Fig. 29 Global Epigenetics Diagnostics Market, For Histone Acetylation, 2018 - 2030 (USD Million)
  • Fig. 30 Global Epigenetics Diagnostics Market, For Large noncoding RNA, 2018 - 2030 (USD Million)
  • Fig. 31 Global Epigenetics Diagnostics Market, For MicroRNA modification, 2018 - 2030 (USD Million)
  • Fig. 32 Global Epigenetics Diagnostics Market, For Chromatin Structure, 2018 - 2030 (USD Million)
  • Fig. 33 Regional Marketplace: Key Takeaways
  • Fig. 34 Regional Outlook, 2022 & 2030
  • Fig. 35 Global Epigenetics Diagnostics Market: Region Movement Analysis
  • Fig. 36 North America Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 38 Canada Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 39 Europe Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 40 Germany Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 41 UK Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 42 France Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 46 Sweden Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 50 China Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 51 India Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 52 Australia Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 53 South Korea Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 54 Thailand Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 55 Latin America Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 56 Brazil Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 57 Mexico Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 58 Argentina Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 59 Middle East And Africa Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 60 South Africa Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 61 Saudi Arabia Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 62 UAE Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)
  • Fig. 63 Kuwait Epigenetics Diagnostics Market, 2018 - 2030 (USD Million)